ArticleFrontiers in pharmacology2022

Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis.

Bingbing Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.